MT Newswires
Viatris, Opus Genetics Say US FDA Agrees to Review New Drug Application for Potential Eye Condition Treatment
➖
AI Sentiment
Neutral
5/10
Viatris Inc. News
Latest updates and market news for VTRS
9 news
Feb 20 - Feb 26, 2026
Page 1
PR Newswire
FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia
📈
AI Sentiment
Highly Positive
8/10
StockStory
Earnings To Watch: Viatris (VTRS) Reports Q4 Results Tomorrow
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Will UBS Upgrade And Inpefa’s First Global Launch Change Viatris' (VTRS) Narrative?
📊
AI Sentiment
Positive
7/10
Zacks
Unveiling Viatris (VTRS) Q4 Outlook: Wall Street Estimates for Key Metrics
➖
AI Sentiment
Neutral
4/10
StockStory
1 Unpopular Stock That Should Get More Attention and 2 Facing Challenges
📉
AI Sentiment
Negative
3/10
Share this news page